Valuation

AZNAstraZeneca PLC

StockNYSE英國Health careEU retail: available

−0.6% today · +3.9% over a year

6/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 71% of the instruments we score

Quality, Dividend safety: among the best of its peers. Dividend yield 1.26%.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricAZNSector medianvs median
P/E26.022.4 · n=2216% above
P/B5.53.6 · n=3950% above
P/S4.54.5 · n=34near the median
EV/EBIT21.121.8 · n=22near the median
Free-cash-flow yield4.4%2.2% · n=37102% above
Dividend yield1.26%0.13% · n=100904% above
Return on equity22.9%4.2% · n=50448% above
Return on invested capital16.4%6.5% · n=41153% above
Gross margin81.9%70.5% · n=3316% above
Net debt / EBITDA—1.39 · n=22—

Value factor: 50 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

InstrumentP/EP/BEV/EBITFree-cash-flow yieldDividend yieldSmart Score
NOVNNovartis AG21.26.417.85.9%2.9%10/10
NVSNovartis AG20.66.317.36.1%3.2%10/10
NVONovo Nordisk A/S11.36.09.95.1%4.7%8/10
SNYSanofi11.61.316.08.0%5.0%7/10
SANSanofi SA11.61.315.98.0%5.6%9/10
TEVATeva Pharmaceutical Industries Limited65.05.936.82.9%0.0%6/10
ALCAlcon AG35.01.627.55.0%0.5%5/10
ALCAlcon34.91.627.55.1%0.5%5/10
ROIVRoivant Sciences Ltd.—6.2—−2.9%0.0%1/10
STESTERIS28.13.121.14.1%0.8%8/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 31 12月 2025 · filed 24 2月 2026